Loading... (0%)
About liver disease
Genfit is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs...
Learn more
NASH: Optimizing therapy for progressive disease April 2016
Watch

Press releases
  • GENFIT Initiates Paediatric NAFLD/NASH Program in Europe Further to the Approval of elafibranor’s Paediatric Investigation Plan by the EMA
    11/14/2016
  • GENFIT Signs an Agreement for the Enhancement of Medical Knowledge & Landscape of NASH Research
    11/10/2016
  • GENFIT: Third Quarter 2016 Financial Information
    11/08/2016
  • GENFIT: FDA has officially cleared the IND to proceed with Phase II trial and evaluate elafibranor in PBC
    11/04/2016
  • GENFIT: Successful identification of RORγt inverse agonists as candidates for regulatory pre-IND studies
    09/23/2016
Events